Quantinuum IPO: Honeywell Unit Raises $1.68 Billion in US Offering

Quantinuum, the quantum computing unit backed by Honeywell, priced an upsized initial public offering on June 3, 2026, selling 28,000,000 Class A shares at $60.00 each and raising approximately $1.68 billion; the Securities and Exchange Commission declared the registration effective and shares are expected to start trading on the Nasdaq under the ticker QNT on June 4, 2026.

The offering included a 30-day option for underwriters to purchase up to an additional 4,200,000 shares to cover over-allotments. Quantinuum’s prospectus shows 2025 revenue of $30.9 million and a net loss of $192.6 million, figures that underline the company’s heavy R&D spend and the gap between current commercial receipts and the valuation implied by the IPO pricing. Recent adjustments to the price range and share count reflected strong institutional demand.

Market observers describe the deal as one of the largest pure-play quantum IPOs to date, with the upsized pricing signaling investor appetite for frontier-technology exposure despite limited near-term revenue. The valuation and pricing put Quantinuum in a high multiple context relative to 2025 sales, and early trading is likely to be driven by sentiment around commercial contracts and technical milestones.

Corporate structure details are material to governance: Honeywell-related entities will beneficially own roughly 49.1% of combined voting power after the offering (approximately 48.5% if the underwriters fully exercise the greenshoe), preserving significant influence over strategic decisions. That arrangement offers strategic support and potential customer synergies but also raises standard considerations for public investors about minority shareholder protections and related-party dynamics.

Analysts expect the IPO proceeds to fund continued product development and commercial expansion, with market expectations focused on whether Quantinuum can translate technical leadership in trapped-ion systems into repeatable, scalable revenue streams. In the near term QNT may trade with elevated volatility as investors assess contract wins, customer pilots and technical progress; over the medium term, government support for quantum technologies and corporate adoption will be key to validating the valuation placed by the IPO.